COMMUNIQUÉS West-GlobeNewswire

Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons
15/07/2026
Delivering versatility for airway procedures in a single, streamlined surgical solution Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the commercial launch of its LYNX COBLATION [...]
BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells
15/07/2026
The formula combines the Xcellara™ mobilization base with Tanshinone IIA, a Danshen-derived compound studied for its effects on the SDF-1α/CXCR4 signaling pathways involved in cellular trafficking and cardiovascular [...]
Lark Health Partners with Samsung to Bring AI-Powered Health Coach to U.S. Seniors
15/07/2026
Through the integration Samsung users will have access to health coaching and eligible Medicare beneficiaries access to Lark’s proven chronic disease management programs, at no out-of-pocket cost MOUNTAIN VIEW, Calif., [...]
NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary Good Salt Life, Inc. Reports Strong Online Retail Growth in First Half of 2026
15/07/2026
ATHENS, Ga., July 15, 2026 (GLOBE NEWSWIRE) -- NDT Pharmaceuticals, Inc. (OTC: NDTP) announces that its wholly owned subsidiary Good Salt Life, Inc. (“GSL” or the “Company”) achieved significant growth across its online [...]
BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
15/07/2026
MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, [...]
Sienna Announces July Dividend
15/07/2026
MARKHAM, Ontario, July 15, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio
15/07/2026
Appointments strengthen financial and scientific leadership to help advance multiple ultra-long-acting incretin and non-incretin therapies toward the clinic EMERYVILLE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Prolynx [...]
Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion
15/07/2026
Delivered strong Q3 financial results: Generated $31.8 million in total net revenues, $13.4 million in gross profit before fair value adjustments, or 42% of revenues, $8.5 million in adjusted EBITDA 1 , and $5.7 million [...]
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
15/07/2026
Data show clade IIb from 2022 outbreak is 100 to 100,000-fold less virulent than clade IIa from 2003 outbreak Three new models for investigating mpox infection and pathogenesis identified Tonix is advancing TNX-801, a [...]
Biogen Appoints Michael J. Parini as Chief Legal Officer
15/07/2026
CAMBRIDGE, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the appointment of Michael J. Parini as Chief Legal Officer, effective August 3, 2026. Parini will serve as a member of [...]
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
15/07/2026
ALLO-316 Achieved a 31% Confirmed Response Rate with the Recommended Phase 2 Regimen in Patients with Stage IV Renal Cell Carcinoma (RCC) with High CD70 Expression Single Dose of ALLO-316 Produced Durable Responses in [...]
Belite Bio to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
15/07/2026
SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative [...]
NOMAD Power Solutions Strengthens Subsidiary Executive Leadership
15/07/2026
Huda Almashhadany Joins Team as Chief of Product & VP of Operations, Company Names Brian Dockendorf as Director of Service Boca Raton, Fla., July 15, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. (“NOMAD” or [...]
aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026
15/07/2026
Patients with restrictive lung disease demonstrate clinically meaningful benefit in FVC and improvements in multiple PROs for 5.0 mg/kg efzofitimod compared to placebo. Company submitted protocol to FDA in June 2026 for [...]
Cardiff Oncology Announces $10 Million Registered Direct Offering
15/07/2026
SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF) (the “Company”), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies, today announced [...]
Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn
15/07/2026
RALEIGH, N.C., July 15, 2026 (GLOBE NEWSWIRE) -- Slate Medicines (Slate), a privately-held biotech company advancing next-generation therapeutics for migraine and other headache disorders, today announced the [...]
Alembic Therapeutics LLC Announces Exclusive U.S. Distribution of NUVESSA® (metronidazole vaginal gel 1.3%)
15/07/2026
BEDMINSTER, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics LLC today announced that it has become the exclusive U.S. distributor of NUVESSA® (metronidazole vaginal gel 1.3%), an FDA-approved prescription [...]
UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103
15/07/2026
PRINCETON, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today [...]
Mixie Technologies, Inc. (OTC: MIXE) Completes Corporate Rebranding and Trading Symbol Change
15/07/2026
Mixie Technologies focuses on acquiring companies and intellectual property built on unique, application-focused technology designed to deliver an advantage to customers, then scales them with AI-driven engineering [...]

Pages